Special clinical interests in benign, urological, gastrointestinal, skin, neurological, head and neck, and Steroetactic Radiosurgery
Chris completed his initial medical and radiation oncology training in Western Australia before undertaking post-graduate studies at Middlesex Hospital (UK), Princess Margaret Hospital (Toronto, Canada), and the Shands Cancer Centre (University of Florida, Gainesville, USA). He is the medical director at GenesisCare Wembley, holds a clinical staff position at Sir Charles Gairdner Hospital, and is accredited as a visiting consultant at a number of private hospitals.
Chris has specialised expertise in advanced radiotherapy techniques including stereotactic radiosurgery, stereotactic body radiation therapy, episcleral plaque brachytherapy for choroidal melanoma, and image guided radiation therapy, including IMRT. He has also completed training on the use of the CyberKnife® Robotic Radiosurgery System.
As an expert in his field, Chris has been involved with many notable committees. For 10 years until 2017, he was on the Medical Advisory Committee at St John of God Subiaco Hospital. He was also chairman of the Radiation Oncology Economics Committee and the Australian Association of Private Radiation Oncology Practices. He is a past board member of the Faculty of Radiation Oncology of the Royal Australian and New Zealand College of Radiologists (RANZCR). He has also been a guest editor for the International Journal of Stereotactic Radiosurgery.
Chris has published over ten papers and is involved in ongoing research projects relating to predominantly prostate, intracranial, lung and spinal tumours.
Did you know?
Chris is keen on everything outdoors from trekking in Nepal to sailing, fishing, gardening, carpentry and DIY home renovation projects. In more quiet moments, he enjoys art, music and reading history.
- Fiona Stanley Hospital
- Sir Charles Gairdner Hospital
Chris’ key clinical interests are in neuro-oncology (brain, skull base and ocular tumours), skin, lower gastrointestinal tumours, head and neck cancers, and urological cancers. His current major technical interests are in the field of stereotactic ablative radiation therapy (SABR).
- American Society for Therapeutic Radiation and Oncology (ASTRO)
- International Stereotactic Radiosurgery Society (ISRS)
- Trans Tasman Radiation Oncology Group (TROG)